{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T12:17:13Z","timestamp":1788265033646,"version":"build-2803163510"},"reference-count":14,"publisher":"BioExcel","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"id":[{"id":"https:\/\/ror.org\/00tjm9378","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DIC"],"abstract":"<jats:p>Background: Heavy menstrual bleeding (HMB) is a common gynaecological condition that significantly affects the quality of life and daily functioning amongst women of reproductive age. In Ayurveda, this condition is described under the category of Asrigdara. Menohelp Syrup, an Ashoka (Saraca asoca)-based Ayurvedic formulation, is traditionally used for the management of HMB. This open-label study evaluated the efficacy and safety of Menohelp Syrup in women with HMB. The study aimed to assess reductions in menstrual blood loss and associated symptoms along with improvement in quality of life.\n\nMethods: This open-label clinical study included 228 non-pregnant women with HMB aged 18\u201345 years. Participants received Menohelp Syrup at a dose of 15 mL twice daily for 90 days. The primary outcome was menstrual blood loss assessed using the Pictorial Blood Assessment Chart. Secondary outcomes included bleeding duration, cycle regularity, pain-related symptoms, haemoglobin and haematological parameters, endometrial thickness, and quality of life assessed using the Menorrhagia Impact Questionnaire.\n\nResults: Treatment with Menohelp Syrup resulted in a substantial reduction in menstrual blood loss, with a 54% decrease in estimated menstrual blood loss and a 58% reduction in Pictorial Blood Assessment Chart scores from baseline to day 90. Improvement was also observed in bleeding duration, absorbent product usage, clot passage and bleeding-related urgency. Menstrual pain symptoms improved considerably, with 68.06% of participants reporting complete resolution of dysmenorrhoea at the end of treatment. Mean haemoglobin levels showed modest improvement, whilst endometrial thickness remained stable throughout the study period. No clinically significant adverse events were reported, indicating a favourable safety profile.\n\nConclusions: Menohelp Syrup was well tolerated and was associated with clinically meaningful improvement in HMB, bleeding-related symptom burden and qualityof- life outcomes in women with HMB. These findings support the potential role of Menohelp Syrup as a safe, non-invasive therapeutic option for the management of HMB.\n\nDownload the Plain Language Summary of this article: https:\/\/www.drugsincontext.com\/plain-language-summaries\/plain-language-summary-efficacy-and-safety-of-an-ayurvedic-menohelp-syrup-in-the-management-of-heavy-menstrual-bleeding-menorrhagia-an-open-label-clinical-study<\/jats:p>","DOI":"10.7573\/dic.2026-3-1","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:40:34Z","timestamp":1788262834000},"page":"1","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of an Ayurvedic Menohelp syrup in the management of heavy menstrual bleeding (menorrhagia): an open-label clinical study"],"prefix":"10.7573","author":[{"given":"Kamini","family":"Dhiman","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00003ef66","id-type":"ROR","asserted-by":"publisher"}],"name":"All India Institute of Ayurveda, New Delhi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep Kumar","family":"Prajapati","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00003ef66","id-type":"ROR","asserted-by":"publisher"}],"name":"All India Institute of Ayurveda, New Delhi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepika","family":"Gopal","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00003ef66","id-type":"ROR","asserted-by":"publisher"}],"name":"All India Institute of Ayurveda, New Delhi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashutosh","family":"Gautam","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00tjm9378","id-type":"ROR","asserted-by":"publisher"}],"name":"Mankind Pharma (India)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajat","family":"Singal","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00tjm9378","id-type":"ROR","asserted-by":"publisher"}],"name":"Mankind Pharma (India)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10047","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"ref0","unstructured":"1.\tDavis E, Sparzak PB. Abnormal Uterine Bleeding (Dysfunctional Uterine Bleeding) [Internet]. Treasure Island, FL: StatPearls Publishing; 2023. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK532913\/. Accessed August 13, 2026."},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"2.\tLaksham KB, Selvaraj R, Kar SS. Menstrual disorders and quality of life of women in an urban area of Puducherry: a community-based cross-sectional study. J Family Med Prim Care. 2019;8(1):137\u2013140. https:\/\/doi.org\/10.4103\/ jfmpc.jfmpc_209_18","DOI":"10.4103\/jfmpc.jfmpc_209_18"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"3.\tMunro MG, Critchley HOD, Fraser IS. The FIGO systems for nomenclature and classification of causes of abnormal uterine bleeding in the reproductive years: who needs them? Am J Obstet Gynecol. 2012;207(4):259\u2013265. https:\/\/ doi.org\/10.1016\/j.ajog.2012.01.046","DOI":"10.1016\/j.ajog.2012.01.046"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"4.\tMaybin JA, Critchley HOD. Medical management of heavy menstrual bleeding. Womens Health. 2016;12(1):27\u201334. https:\/\/doi.org\/10.2217\/whe.15.100","DOI":"10.2217\/whe.15.100"},{"key":"ref4","unstructured":"5.\tWorld Health Organization. WHO Traditional Medicine Strategy: 2014\u20132023. Geneva: World Health Organization; 2013. https:\/\/www.who.int\/publications\/i\/item\/9789241506096. Accessed August 13, 2026."},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"6.\tDebnath P, Banerjee S, Adhikari A, Debnath PK. Ayurpharmacoepidemiology en route to safeguarding safety and efficacy of ayurvedic drugs in global outlook. J Evid Based Complement Alternat Med. 2016;22(2):294\u2013298. https:\/\/ doi.org\/10.1177\/2156587215624032","DOI":"10.1177\/2156587215624032"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"7.\tKarache AS, Mehere S. Complete review of Ayurvedic management of Raktapradar w.s.r. to Brihatrayi and Laghutrayi. Int J Ayu Pharm Res. 2021;9(9):51\u201358. https:\/\/doi.org\/10.47070\/ijapr.v9i9.2075","DOI":"10.47070\/ijapr.v9i9.2075"},{"key":"ref7","unstructured":"8.\tLakshmi V. Ayurvedic approach of menorrhagia: Asrigdara. Int J Ayu Pharm Res. 2017;5(6):55\u201359. https:\/\/ijapr.in\/ index.php\/ijapr\/article\/view\/694"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"9.\tUrumarudappa SKJ, Rosario S, Ravikanth G, Sukrong S. A comprehensive review on Saraca asoca (Fabaceae) \u2013 historical perspective, traditional uses, biological activities, and conservation. J Ethnopharmacol. 2023;317:116861. https:\/\/doi.org\/10.1016\/j.jep.2023.116861","DOI":"10.1016\/j.jep.2023.116861"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"10.\tSwar G, Shailajan S, Menon S. Activity-based evaluation of a traditional Ayurvedic medicinal plant: Saraca asoca (Roxb.) de Wilde flowers as estrogenic agents using an ovariectomized rat model. J Ethnopharmacol. 2017;195:324\u2013333. https:\/\/doi.org\/10.1016\/j.jep.2016.11.038","DOI":"10.1016\/j.jep.2016.11.038"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"11.\tSalvi S, Varghese R, Digholkar G, Deshpande A, Malvankar C, Pawar A, et al. Saraca asoca: a scoping review on the phytoconstituents, bioactives and their therapeutic effects. Ger J Pharm Biomater. 2022;1(3):3\u201313. https:\/\/ doi.org\/10.5530\/gjpb.2022.3.11","DOI":"10.5530\/gjpb.2022.3.11"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"12.\tHigham JM, O\u2019Brien PMS, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. BJOG. 1990;97(8):734\u2013739. https:\/\/doi.org\/10.1111\/j.1471-0528.1990.tb16249.x","DOI":"10.1111\/j.1471-0528.1990.tb16249.x"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"13.\tAl-Snafi AE. A review on Cyperus rotundus: a potential medicinal plant. IOSR J Pharm. 2016;6(7):32\u201348. https:\/\/ doi.org\/10.9790\/3013-06723248","DOI":"10.9790\/3013-06723248"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"14.\tYing J, Bing X. Chemical constituents of Cyperus rotundus L. and their inhibitory effects on uterine fibroids. Afr Health Sci. 2016;16(4):1000\u20131006. https:\/\/doi.org\/10.4314\/ahs.v16i4.16","DOI":"10.4314\/ahs.v16i4.16"}],"container-title":["Drugs in Context"],"original-title":[],"link":[{"URL":"https:\/\/www.drugsincontext.com\/wp-content\/uploads\/2026\/09\/dic.2026-3-1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:40:36Z","timestamp":1788262836000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.drugsincontext.com\/efficacy-and-safety-of-an-ayurvedic-menohelp-syrup-in-the-management-of-heavy-menstrual-bleeding-menorrhagia-an-open-label-clinical-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7573\/dic.2026-3-1","relation":{},"ISSN":["1740-4398","1740-4398"],"issn-type":[{"value":"1740-4398","type":"print"},{"value":"1740-4398","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"article-number":"dic.2026-3-1"}}